Clinical Trial Update: Dexmedetomidine for Invasive Ventilation In the NEOnate [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 studies are evaluating dexmedetomidine for sedation during invasive ventilation in neonates; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Failure

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Centre Hospitalier Intercommunal Creteil | Conditions: Invasive Ventilation, Infant Pain | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING